Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALL-11 treatment protocol for pediatric and adolescent acute lymphoblastic leukemia
2012-000067-25Phase 3Completed
- Sponsor
- Princess Máxima Center for Pediatric Oncology
- Start
- Jul 2012
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pegaspargase in acute lymphoblastic leukemia (ALL), sponsored by Princess Máxima Center for Pediatric Oncology. Primary endpoint: Overall survival. Started Jul 2012; status: completed.
02
Drugs
pegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2012-000067-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000067-25.